According to the report … 78% of all participants in clinical trials dating to 2011 were white. Latinos, who are 18% of the U.S. population, were 12% of participants and Black Americans, who are more than 12% of the total population, accounted for 11% of participants. Asian, Native Hawaiian and Pacific Islander participants were equitably represented in vaccine trials compared to the total population, the authors found.